Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascend Wellness Holdings (AAWH) EBITDA (2020 - 2025)

Ascend Wellness Holdings has reported EBITDA over the past 6 years, most recently at -$17.2 million for Q4 2025.

  • Quarterly results put EBITDA at -$17.2 million for Q4 2025, down 381.58% from a year ago — trailing twelve months through Dec 2025 was -$17.0 million (down 459.36% YoY), and the annual figure for FY2025 was -$17.0 million, down 459.36%.
  • EBITDA for Q4 2025 was -$17.2 million at Ascend Wellness Holdings, down from -$1.3 million in the prior quarter.
  • Over the last five years, EBITDA for AAWH hit a ceiling of $11.6 million in Q3 2021 and a floor of -$32.0 million in Q1 2021.
  • Median EBITDA over the past 5 years was -$175000.0 (2022), compared with a mean of -$2.0 million.
  • Biggest five-year swings in EBITDA: tumbled 1383.08% in 2021 and later skyrocketed 981.21% in 2024.
  • Ascend Wellness Holdings' EBITDA stood at -$731000.0 in 2021, then skyrocketed by 836.25% to $5.4 million in 2022, then crashed by 89.52% to $564000.0 in 2023, then skyrocketed by 981.21% to $6.1 million in 2024, then plummeted by 381.58% to -$17.2 million in 2025.
  • The last three reported values for EBITDA were -$17.2 million (Q4 2025), -$1.3 million (Q3 2025), and -$1.0 million (Q2 2025) per Business Quant data.